S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)

Glaukos (GKOS) Stock Forecast & Price Target

$79.49
-0.93 (-1.16%)
(As of 12/29/2023 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Glaukos Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 10 Analyst Ratings

Analysts' Consensus Price Target

$87.30
9.83% Upside
High Forecast$105.00
Average Forecast$87.30
Low Forecast$65.00
TypeCurrent Forecast
12/31/22 to 12/31/23		1 Month Ago
12/1/22 to 12/1/23		3 Months Ago
10/2/22 to 10/2/23		1 Year Ago
12/31/21 to 12/31/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$87.30$81.90$79.00$56.67
Predicted Upside9.83% Upside26.31% Upside19.73% Upside18.71% Upside
Get Glaukos Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.


GKOS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GKOS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Glaukos Stock vs. The Competition

TypeGlaukosMedical CompaniesS&P 500
Consensus Rating Score
2.80
2.67
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside9.83% Upside2,167.34% Upside6.98% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/29/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$100.00+24.35%
12/22/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight ➝ Overweight$90.00 ➝ $105.00+23.53%
12/21/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Overweight$66.00 ➝ $91.00+14.32%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageEqual Weight$65.00-0.20%
11/8/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeEqual Weight ➝ Overweight$75.00 ➝ $83.00+33.16%
11/2/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$89.00 ➝ $83.00+29.36%
9/26/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$90.00+17.26%
8/3/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$83.00 ➝ $86.00+15.14%
8/3/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$80.00 ➝ $85.00+13.80%
7/10/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$59.00 ➝ $85.00+22.78%
5/4/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingMaintains
2/22/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Kaczor
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:44 PM ET.












GKOS Price Target - Frequently Asked Questions

What is Glaukos's consensus rating and price target?

According to the issued ratings of 10 analysts in the last year, the consensus rating for Glaukos stock is Moderate Buy based on the current 2 hold ratings and 8 buy ratings for GKOS. The average twelve-month price prediction for Glaukos is $87.30 with a high price target of $105.00 and a low price target of $65.00. Learn more on GKOS's analyst rating history.

Do Wall Street analysts like Glaukos more than its competitors?

Analysts like Glaukos more than other Medical companies. The consensus rating score for Glaukos is 2.80 while the average consensus rating score for medical companies is 2.67. Learn more on how GKOS compares to other companies.

Is Glaukos being upgraded by Wall Street analysts?

Over the previous 90 days, Glaukos's stock had 2 upgrades by analysts.

Does Glaukos's stock price have much upside?

According to analysts, Glaukos's stock has a predicted upside of 21.03% based on their 12-month stock forecasts.

What analysts cover Glaukos?

Glaukos has been rated by JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Piper Sandler, Truist Financial, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:GKOS) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -